Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 10 November 2009, doi:10.1136/bmj.b4680
Cite this as: BMJ 2009;339:b4680
Susan Mayor
1 London
| The first 150 words of the full text of this article appear below. |
The number of patients infected with meticillin resistant Staphylococcus aureus (MRSA) and Clostridium difficile in hospitals in England has fallen, says a parliamentary report published this week. But it warns that other healthcare associated infections are increasing because they are not subject to mandatory monitoring.
The Public Accounts Committee, which is appointed by the House of Commons to examine public expenditure, has been reporting on healthcare acquired infections—which it considers a key indicator of quality and safety of NHS care—since 2000, when it found that "the NHS did not have a grip on the extent and costs of hospital acquired infection."
Mandatory reporting of MRSA infections was introduced in 2001, when the numbers were among the highest in Europe, and for C difficile in 2004. The latest data show that the number of MRSA bloodstream infections in 2008-9 fell by 62% from the 2003-4 figure (from 7700 to 2932).
Figures
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses